KRAS P34R [plasma membrane]

Stable Identifier
R-HSA-9651276
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
20949621 Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders

Cirstea, IC, Ahmadian, MR, Merbitz-Zahradnik, T, Zenker, M, Dvorsky, R, Gremer, L, Wittinghofer, A, Kratz, CP

Hum. Mutat. 2011
Participates
Other forms of this molecule
Modified Residues
Name
L-proline 34 replaced with L-arginine
Coordinate
34
PsiMod
A protein modification that effectively removes or replaces an L-proline.
A protein modification that effectively converts a source amino acid residue to an L-arginine.
Disease
Name Identifier Synonyms
cardiofaciocutaneous syndrome DOID:0060233 CFC syndrome, cardio-facial-cutaneous syndrome
urinary system cancer DOID:3996
Cross References
Guide to Pharmacology - Targets
ClinGen
OpenTargets
ZINC - Substances
ZINC target
PRO
PDB
7R0M, 7RT2, 7SCX, 2MSE, 8VRA, 6PGO, 7EYX, 6GOD, 8G9Q, 7T1F, 6QUX, 6GOM, 4M1O, 7OK3, 5V6S, 6FA2, 8DGT, 4EPT, 7O70, 1N4Q, 6YXW, 5WHA, 5MLA, 6N2K, 6MTA, 7LZ5, 7KFZ, 5UFQ, 6GJ6, 7LC2, 7YV1, 8T71, 5UQW, 9BG1, 4QL3, 8TXJ, 6MQN, 5UK9, 6BOF, 6P8W, 4OBE, 8B78, 5OCT, 6MBQ, 8QW7, 7MQU, 3GFT, 8X6R, 8TBJ, 4EPY, 6P0Z, 4M1S, 6PGP, 6QUV, 5XCO, 7LGI, 8TXE, 4Q02, 5US4, 8FMK, 8WTE, 4LV6, 6M9W, 1N4R, 8DGS, 8AFC, 6F76, 7ACA, 7OO7, 8AZX, 1KZP, 5V9U, 7TLE, 6EPN, 6V6F, 8TY9, 6WGN, 7YCE, 8AZZ, 4TQ9, 1D8E, 8G4H, 8S8C, 7SCW, 8PI0, 6MBT, 4LRW, 5UFE, 4WA7, 4EPR, 4LPK, 5YY1, 1D8D, 4EPX, 6GOE, 7U8H, 8G9P, 6GQW, 4Q01, 7EW9, 6MQG, 6O51, 8G47, 6EPL, 8DNI, 8CPR, 1N4S, 8B69, 1KZO, 9AX6, 4LDJ, 4NMM, 6OB2, 8QVU, 6BP1, 6O36, 6WS4, 8I5E, 6O4Y, 7NY8, 6VC8, 8AZY, 7STF, 7RT1, 7C41, 7RP4, 6E6G, 6PTW, 6ZLI, 7W5R, 6V5L, 8AQ5, 5OCG, 6JTP, 6ZL5, 6ASA, 8I5C, 5O2S, 8TBM, 6GQT, 7VVB, 8T4V, 5VPI, 6W4E, 8TXG, 8CX5, 7TLK, 8G42, 6JTN, 6XHB, 8T74, 8ONV, 8F0M, 8I5D, 6FA3, 5WHD, 8AZR, 6EPO, 6T5B, 5WLB, 7A47, 8TBN, 5VPY, 8DVG, 5W22, 7RP3, 4PZZ, 8QW6, 7ACH, 8AFB, 8JHL, 8STN, 6GJ7, 5V6V, 2MSC, 4M1W, 8WUL, 7RPZ, 8TBL, 6QUW, 8EER, 6P8Z, 4EPW, 8FMJ, 5TB5, 8JJS, 8BE3, 6WS2, 8EIE, 6O4Z, 8VRB, 6JTO, 7F0W, 6MS9, 7R0Q, 8EBZ, 8BLR, 6CCX, 6E6F, 6FA4, 8UDR, 8UN4, 8BE4, 4DSO, 8T73, 4LYJ, 8TXH, 8ECR, 6V65, 7C40, 8VR9, 5VPZ, 7RT4, 7A1Y, 5VQ2, 4Q03, 8STM, 4PZY, 6USZ, 9BFY, 8AQ7, 5KYK, 6B0Y, 6ARK, 6P8X, 8JGD, 7RT5, 6W4F, 8FMI, 5WHE, 6FA1, 6XHA, 6VJJ, 8DNK, 6XGU, 6PQ3, 4LYH, 8UN5, 8T75, 7ACQ, 8UN3, 7LC1, 6EPP, 8TY2, 5WPM, 8G4F, 6GOF, 5VQ0, 8TBF, 4M22, 7A1W, 6QUU, 7RSC, 5VBM, 6H46, 5V9O, 7RP2, 6GJ8, 7KMR, 7OK4, 6YR8, 6UT0, 6CCH, 8QU8, 2MSD, 5O2T, 5WHB, 7YCC, 4LUC, 7EWA, 5V71, 7ROV, 1N4P, 6XGV, 6N2J, 6ASE, 8DNJ, 6TAM, 6GJ5, 4L8G, 6PTS, 5V9L, 7KYZ, 4DSN, 7EWB, 7MDP, 6O46, 8EZG, 8TXK, 5OCO, 6MBU, 5VP7, 8TBH, 6GQX, 5VQ1, 5VQ8, 7RT3, 7A1X, 8R7X, 6H47, 7ACF, 5YXZ, 8AFD, 6T5U, 6B0V, 6P8Y, 4M1T, 5VQ6, 7T47, 8TBK, 7RSE, 8EPW, 4EPV, 8BE5, 6MNX, 7YUZ, 8B6I, 7R0N, 5MLB, 7TLG, 5TAR, 6USX, 6TAN, 8T72, 6OIM, 7Q9U, 8AZV, 5F2E, 8TVK, 6OB3, 6EPM, 8TY8, 6CU6, 4LYF, 5USJ, 6O53, 6CC9, 6GOG, 8B00, 4M21, 4TQA, 6GQY, 8EDY, 8QUG, 4M1Y, 6T5V, 8R7W
COSMIC
GeneCards
Pharos - Targets
Orphanet
HMDB Protein
Interactors (13)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P04049 RAF1  20 0.695 6
 UniProt:Q99755 PIP5K1A  1 0.661 9
 UniProt:P15056 BRAF  20 0.615 4
 UniProt:Q96II5 Q96II5      0.556 3
 UniProt:P50749 RASF2      0.544 2
 UniProt:O75915 ARL6IP5  1 0.519 2
 UniProt:P61586 RHOA  6 0.519 2
 UniProt:P10398 ARAF  4 0.483 2
 UniProt:P28288 ABCD3  2 0.483 2
 UniProt:P01111 NRAS  20 0.483 2
 UniProt:Q7KZI7 MARK2      0.483 2
 UniProt:Q9UQB8 BAIAP2  1 0.483 2
 ChEBI:16618 1-PHOSPHATIDYL-1D-MYO-INOSITOL 3,4,5-TRISPHOSPHATE      0.462 2
Cite Us!